Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yanjie Hao

Showing results (11-20 of 61) with videos related to

Pageof 7
Sort By:
Frontiers in Immunology|October 15, 2025
Impact of Sjögren's disease and its immunological characteristics on reaching remission or low disease activity state in systemic lupus erythematosus patients: a propensity score-matched longitudinal studyHaoze Zhang, Huijuan Zhang, Dai Gao, et al.
Oncology Reports|September 26, 2025
REV1‑targeting inhibitor JH‑RE‑06 induces ferroptosis via NCOA4‑mediated ferritinophagy in colorectal cancer cellsJianhua Cheng, Xiaoxia Yang, Wen Zhao, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|July 18, 2023
Assessment of peripapillary retinal nerve fiber layer thickness and vessel density in newly diagnosed SLE patients without ocular symptomsXin Rong, Xiaona Sun, Yanjie Hao, et al.
Arthritis Research & Therapy|October 30, 2021
Treatments and outcomes in Chinese patients with serologically active clinically quiescent systemic lupus erythematosus: a retrospective observational studyHong Huang, Lin Mu, Zhuoli Zhang, et al.
Clinical Rheumatology|January 6, 2020
Mortality of Chinese patients with polymyositis and dermatomyositisXinlei Yang, Yanjie Hao, Xiaohui Zhang, et al.
Rheumatology (Oxford, England)|April 28, 2020
Frequencies and predictors of the Lupus Low Disease Activity State and remission in treatment-naïve patients with systemic lupus erythematosusDai Gao, Yanjie Hao, Lin Mu, et al.
Frontiers in Immunology|April 4, 2025
Transitioning from Lupus Low Disease Activity State to remission in systemic lupus erythematosus: real-world evidenceDai Gao, Lanlan Ji, Xiaohui Zhang, et al.
International Journal of Medical Sciences|August 22, 2017
Cysteine-rich 61 (Cyr61) upregulated in pulmonary arterial hypertension promotes the proliferation of pulmonary artery smooth muscle cellsLan Gao, Yong Fan, Yanjie Hao, et al.
Rheumatology (Oxford, England)|April 12, 2022
Low-dose glucocorticoids withdrawn in systemic lupus erythematosus: a desirable and attainable goalLanlan Ji, Dai Gao, Yanjie Hao, et al.
Rheumatology and Therapy|July 7, 2023
Comparison of the Effectiveness and Safety of Mycophenolate Mofetil and Cyclophosphamide in Lupus Nephritis: Evidence from a Real-World StudyXiaohui Zhang, Hong Huang, Dai Gao, et al.
Pageof 7

Showing results (11-20 of 61) with videos related to

Sort By:
Pageof 7
Frontiers in Immunology|October 15, 2025
Impact of Sjögren's disease and its immunological characteristics on reaching remission or low disease activity state in systemic lupus erythematosus patients: a propensity score-matched longitudinal studyHaoze Zhang, Huijuan Zhang, Dai Gao, et al.
Oncology Reports|September 26, 2025
REV1‑targeting inhibitor JH‑RE‑06 induces ferroptosis via NCOA4‑mediated ferritinophagy in colorectal cancer cellsJianhua Cheng, Xiaoxia Yang, Wen Zhao, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|July 18, 2023
Assessment of peripapillary retinal nerve fiber layer thickness and vessel density in newly diagnosed SLE patients without ocular symptomsXin Rong, Xiaona Sun, Yanjie Hao, et al.
Arthritis Research & Therapy|October 30, 2021
Treatments and outcomes in Chinese patients with serologically active clinically quiescent systemic lupus erythematosus: a retrospective observational studyHong Huang, Lin Mu, Zhuoli Zhang, et al.
Clinical Rheumatology|January 6, 2020
Mortality of Chinese patients with polymyositis and dermatomyositisXinlei Yang, Yanjie Hao, Xiaohui Zhang, et al.
Rheumatology (Oxford, England)|April 28, 2020
Frequencies and predictors of the Lupus Low Disease Activity State and remission in treatment-naïve patients with systemic lupus erythematosusDai Gao, Yanjie Hao, Lin Mu, et al.
Frontiers in Immunology|April 4, 2025
Transitioning from Lupus Low Disease Activity State to remission in systemic lupus erythematosus: real-world evidenceDai Gao, Lanlan Ji, Xiaohui Zhang, et al.
International Journal of Medical Sciences|August 22, 2017
Cysteine-rich 61 (Cyr61) upregulated in pulmonary arterial hypertension promotes the proliferation of pulmonary artery smooth muscle cellsLan Gao, Yong Fan, Yanjie Hao, et al.
Rheumatology (Oxford, England)|April 12, 2022
Low-dose glucocorticoids withdrawn in systemic lupus erythematosus: a desirable and attainable goalLanlan Ji, Dai Gao, Yanjie Hao, et al.
Rheumatology and Therapy|July 7, 2023
Comparison of the Effectiveness and Safety of Mycophenolate Mofetil and Cyclophosphamide in Lupus Nephritis: Evidence from a Real-World StudyXiaohui Zhang, Hong Huang, Dai Gao, et al.
Pageof 7